Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 267 K269 K261 K1.29 M1.15 M5.22 M 7.92 M Research & development —————— — Operating income -267 K-269 K-261 K-1.29 M-1.15 M-5.22 M -7.92 M Non-Operating Income, Total 660 K2.16 M2.17 M2.02 M1.85 M1.87 M 7.92 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 660 K2.16 M2.17 M2.02 M1.85 M1.87 M 7.92 M Unusual income/expense —————— — Pretax income 393 K1.89 M1.91 M726 K704 K-3.35 M -4 000 Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 393 K1.89 M1.91 M726 K704 K-3.35 M -4 000 Discontinued operations —————— — Net income 393 K1.89 M1.91 M726 K704 K-3.35 M -4 000 Dilution adjustment 14.71 M2.14 M2.16 M2.01 M439 K— — Preferred dividends 14.71 M2.14 M2.16 M2.01 M1.85 M— — Diluted net income available to common stockholders 393 K1.89 M1.91 M726 K-704 K3.35 M 5.28 M Basic earnings per share (Basic EPS) 0.040.080.070.020.02-0.12 -0.01 Diluted earnings per share (Diluted EPS) 0.040.080.070.020.02-0.12 -0.01 Average basic shares outstanding 6.74 M13.74 M16.16 M17.35 M20.91 M20.91 M — Diluted shares outstanding 6.74 M13.74 M16.16 M17.35 M20.91 M20.91 M — EBITDA —————— — EBIT 393 K1.89 M1.91 M—-1.14 M-5.21 M — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —